🧬
Our colorectal cancer program investigates the rising incidence of young-onset disease in India and develops precision medicine strategies for advanced-stage patients.
Learn MoreEpidemiological and molecular studies investigating why colorectal cancer rates are rising among Indian adults under 50.
Checkpoint inhibitor monotherapy and combinations for microsatellite instability–high colorectal cancers.
Using circulating tumour DNA to identify stage II/III patients who can safely omit adjuvant chemotherapy.
Evaluating faecal immunochemical testing and colonoscopy as cost-effective screening approaches in the Indian context.
NCT06234514
RecruitingPI: Dr. T. Rajkumar
NCT06234515
ActivePI: Dr. Mayilvahanan Bose
Your generosity supports research into why colorectal cancer is striking younger Indians and funds clinical trials of less invasive treatment approaches.
Donate Now
.png&w=96&q=75){kind=small}